Anxiety Disorders Clinical Trial
Official title:
Transdiagnostic Interventions for Emotional Disorders
NCT number | NCT03855683 |
Other study ID # | 15-061 |
Secondary ID | |
Status | Suspended |
Phase | N/A |
First received | |
Last updated | |
Start date | March 6, 2019 |
Est. completion date | February 2022 |
Verified date | September 2020 |
Source | Palo Alto University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to identify cognitive mechanisms that might facilitate treatment
response for individuals experiencing depression and/or anxiety. The Stress, Anxiety, and
Mood group helps individuals experiencing symptoms of stress, anxiety, and mood by providing
concrete coping skills to regulate emotions, to let go of negative thoughts, and build
courage to talk to others about tough topics. Groups meet for 8 weeks, with sessions lasting
90 minutes each. In addition to group therapy, you will be asked to complete some
computerized and paper and pencil-based tasks.
If you are interested in learning more, please contact us at 650-417-2000 ext. 3642 or
paloalto.study@gmail.com. All inquiries will be kept strictly confidential.
Status | Suspended |
Enrollment | 50 |
Est. completion date | February 2022 |
Est. primary completion date | February 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Normal color vision - Ability to travel to Palo Alto University - Experiencing symptoms of stress, anxiety, and/or depression |
Country | Name | City | State |
---|---|---|---|
United States | Palo Alto University | Los Altos | California |
Lead Sponsor | Collaborator |
---|---|
Palo Alto University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Level of depression as measured by the following questionnaire: | Mood and Anxiety Symptom Questionnaire- Anhedonic Depression subscale | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of intolerance of uncertainty as measured by the following questionnaire: | Intolerance of Uncertainty Questionnaire | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of rumination and reflection as measured by the following questionnaire: | Rumination Reflection Questionnaire | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of anxious arousal as measured by the following questionnaire: | Mood and Anxiety Symptom Questionnaire- Anxious Apprehension subscale | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of anxious apprehension as measured by the following questionnaire: | Penn State Worry Questionnaire | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of alcohol use as measured by the following questionnaire: | Alcohol Use Disorders Identification Test | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of positive and negative emotions as measured by the following questionnaire: | The Positive and Negative Affect Schedule | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of behavioral regulation and metacognition as measured by the following questionnaire: | Behavioral Regulation Index and Metacognition Index | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of trait mood as measured by the following questionnaire: | Trait Meta-Mood Scale. | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of emotion regulation as measured by the following questionnaire: | Emotion Regulation Questionnaire | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of mental imagery as measured by the following questionnaire: | Questionnaire of Mental Imagery | The change from baseline and post-treatment, approximately 8 weeks after baseline | |
Primary | Level of cognitive functioning via neuropsychological testing session | Objective assessment of cognitive strengths and weaknesses | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03535805 -
Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Recruiting |
NCT05419934 -
EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial
|
N/A | |
Active, not recruiting |
NCT04136054 -
Better Sleep in Psychiatric Care - Anxiety and Affective Disorders
|
N/A | |
Completed |
NCT04091139 -
Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong
|
Phase 2/Phase 3 | |
Completed |
NCT04647318 -
Physiological Response to Self-compassion Versus Relaxation
|
N/A | |
Active, not recruiting |
NCT05114824 -
Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students
|
N/A | |
Recruiting |
NCT05843695 -
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
|
N/A | |
Completed |
NCT05078450 -
Mood Lifters Online for Graduate Students and Young Professionals
|
N/A | |
Not yet recruiting |
NCT06162624 -
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
|
N/A | |
Not yet recruiting |
NCT05747131 -
Emotion Detectives In-Out: Feasibility and Efficacy of a Blended Version of the Unified Protocol for Children
|
N/A | |
Not yet recruiting |
NCT05863637 -
Intensive Short-Term Dynamic Psychotherapy (ISTDP) for Anxiety Diagnoses in a Primary Care Setting
|
N/A | |
Not yet recruiting |
NCT05225701 -
Efficacy of a Transdiagnostic Guided Internet-Delivered Intervention for Emotional, Trauma and Stress-Related Disorders.
|
N/A | |
Completed |
NCT02579915 -
Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC)
|
N/A | |
Recruiting |
NCT02376959 -
Effect of Spiritist "Passe" Energy Therapy in Reducing Anxiety in Volunteers
|
N/A | |
Recruiting |
NCT02186366 -
Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen Type
|
N/A | |
Not yet recruiting |
NCT02126787 -
Short-term, Intensive Psychodynamic Group Therapy Versus Cognitive-behavioral Group Therapy in the Day Treatment
|
N/A | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT02134730 -
School-based Universal Prevention for Anxiety and Depression in Sweden: A Cluster-randomized Trial
|
N/A | |
Completed |
NCT01333098 -
Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
|
Phase 1/Phase 2 |